News

Article

New FDA Guidance on Electronic Common Technical Document Submissions

Author(s):

New FDA Guidance on Electronic Common Technical Document Submissions

On Nov. 28, the US Food and Drug Administration released a new guidance covering the content of electronic common technical document (eCTD) submissions. The new Guidance for Industry: Providing Regulatory Submissions in Electronic Format-Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications, updates the August 2003 draft guidance on the same topic.

The new guidance provides more specificity than earlier guidances regarding the organization of electronic submissions, and it harmonizes the organization and formatting of multiple submission types. The International Conference on Harmonization developed the CTD and the eCTD for marketing approval applications (ANDAs, BLAs, NDAs), but according to the new guidance, they can apply to other submission types such as INDs and master files. More details regarding the ICH eCTD can be found in the ICH guidance document M2 eCTD:  Electronic Common Technical Document Specification.  

The new FDA guidance is available at:

http://www.fda.gov/cder/guidance/6766fnl.htm

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content